Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: PHLORIDZIN 3C: The Homoeopthic drug Phloridzin, “produce the diabetes and fatty degeneration of the liver: intermittent fever. daily doses,15 grains. Phloridzin causes glycosuria.no hyp
Sponsors
DR KUMARAVEL V
Eligibility
Inclusion criteria
Inclusion criteria: The patient having high risk for diabetes as per Indian diabetes risk score (IDRS >60) with or without Diagnosed case of Diabetes mellitus type-II (ICD-10:E11.9-Type-2 Diabetes Mellitus without complication) as per WHO diagnostic criteria and symptomatic (polyuria, polydipsia and polyphagia) with i. Age: 19-65Yrs ii. Both Sexes iii. Fasting blood glucose level (FBS) > 126mg/dl or Postprandial blood Glucose (PPBS) > 200mg/dl or Glycated Haemoglobin (HbA1C ) > 6.5 % or Random blood glucose level (RBS) > 200mg/dl iv. Providing written informed consent to participate
Exclusion criteria
Exclusion criteria: i. Pregnant women, Lactating women & paediatric age group ( ii. Person under corticosteroid therapy or substance abuse iii. Diagnosed case of type I diabetes mellitus or diabetic ketoacidosis with in past 6 mts iv. Uncontrolled hypertension or >2 episodes of sever hypoglycaemia within past 6 mts v. Patient suffering from Diabetes mellitus type-II with complication like retinopathy, nephropathy, neuropathy and other severe infectious diseases. vi. Patients who are too sick for consultation and not willing to cooperate vii. Unwilling to take part and not giving consent to join the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Primary: Blood sugar (fasting and post-prandial (After 2hr))Timepoint: 6 MONTH | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1C %, Blood lipid profile, plasma urea and creatinineTimepoint: 6 MONTH | — |
Countries
India
Contacts
Public ContactKUMARAVEL V
NATIONAL INSTITUTE OF HOMOEOPATHY
Outcome results
None listed